{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T11:38:53Z","timestamp":1790163533361,"version":"4.1.0"},"reference-count":49,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2009,8,1]],"date-time":"2009-08-01T00:00:00Z","timestamp":1249084800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The American Journal of Pathology"],"published-print":{"date-parts":[[2009,8]]},"DOI":"10.2353\/ajpath.2009.080451","type":"journal-article","created":{"date-parts":[[2009,7,17]],"date-time":"2009-07-17T01:44:49Z","timestamp":1247795089000},"page":"817-824","source":"Crossref","is-referenced-by-count":14,"title":["Activation of mTORC1 Signaling Pathway in AIDS-Related Lymphomas"],"prefix":"10.1016","volume":"175","author":[{"given":"Mouna","family":"El-Salem","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Puthiyaveettil N.","family":"Raghunath","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michal","family":"Marzec","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaobin","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monika","family":"Kasprzycka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erle","family":"Robertson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariusz A.","family":"Wasik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.2353\/ajpath.2009.080451_bib1","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1038\/sj.cr.7290372","article-title":"AIDS related lymphomas","volume":"15","author":"Wood","year":"2005","journal-title":"Cell Res"},{"key":"10.2353\/ajpath.2009.080451_bib2","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1002\/cncr.21562","article-title":"Changes in acquired immuno-deficiency syndrome-related non-Hodgkin lymphoma in the era of highly active antiretroviral therapy: incidence, presentation, treatment, and survival","volume":"106","author":"Diamond","year":"2006","journal-title":"Cancer"},{"key":"10.2353\/ajpath.2009.080451_bib3","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1002\/jemt.20230","article-title":"AIDS-related non-Hodgkin's lymphomas","volume":"68","author":"Krause","year":"2005","journal-title":"Microsc Res Tech"},{"key":"10.2353\/ajpath.2009.080451_bib4","series-title":"World Health Organization Classification of Tumours, Tumours of the Hematopoietic and Lymphoid Tissues","first-page":"260","article-title":"Lymphomas associated with infection by the human immune deficiency virus (HIV)","author":"Raphael","year":"2001"},{"key":"10.2353\/ajpath.2009.080451_bib5","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1038\/nrc1974","article-title":"mTOR and cancer: insights into a complex relationship","volume":"6","author":"Sabatini","year":"2006","journal-title":"Nat Rev Cancer"},{"key":"10.2353\/ajpath.2009.080451_bib6","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1038\/sj.bjc.6602902","article-title":"mTOR signaling: implications for cancer and anticancer therapy","volume":"94","author":"Petroulakis","year":"2006","journal-title":"Br J Cancer"},{"key":"10.2353\/ajpath.2009.080451_bib7","doi-asserted-by":"crossref","first-page":"6347","DOI":"10.1038\/sj.onc.1209885","article-title":"Upstream of the mammalian target of rapamycin: do all roads pass through mTOR?","volume":"25","author":"Corradettia","year":"2006","journal-title":"Oncogene"},{"key":"10.2353\/ajpath.2009.080451_bib8","doi-asserted-by":"crossref","first-page":"5256","DOI":"10.1002\/j.1460-2075.1996.tb00911.x","article-title":"Direct inhibition of the signaling functions of the mammalian target of rapamycin by the phosphoinositide 3-kinase inhibitors, wortmannin and LY294002","volume":"15","author":"Brunn","year":"1996","journal-title":"EMBO J"},{"key":"10.2353\/ajpath.2009.080451_bib9","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1042\/bj3440427","article-title":"Mammalian target of rapamycin is a direct target for protein kinase B: Identification of a convergence point for opposing effects of insulin and amino-acid deficiency on protein translation","volume":"344","author":"Nav\u00e9","year":"1999","journal-title":"Biochem J"},{"key":"10.2353\/ajpath.2009.080451_bib10","first-page":"3504","article-title":"A direct linkage between the phosphoinositide 3-kinase-AKT signaling pathway and the mammalian target of rapamycin in mitogen-stimulated and transformed cells","volume":"60","author":"Sekuli\u0107","year":"2000","journal-title":"Cancer Res"},{"key":"10.2353\/ajpath.2009.080451_bib11","doi-asserted-by":"crossref","first-page":"37288","DOI":"10.1074\/jbc.M303257200","article-title":"Inactivation of the tuberous sclerosis complex-1 and -2 gene products occurs by phosphoinositide 3-kinase\/Akt-dependent and independent prosphorylation of tuberin","volume":"278","author":"Tee","year":"2003","journal-title":"J Biol Chem"},{"key":"10.2353\/ajpath.2009.080451_bib12","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.cell.2005.02.031","article-title":"Phosphorylation and functional inactivation of TSC2 by Erk implications for tuberous sclerosis and cancer pathogenesis","volume":"121","author":"Ma","year":"2005","journal-title":"Cell"},{"key":"10.2353\/ajpath.2009.080451_bib13","doi-asserted-by":"crossref","first-page":"2271","DOI":"10.1056\/NEJMoa066838","article-title":"Global ARCC Trial. Temsirolimus, interferon alfa, or both for advanced renal-cell carcinoma","volume":"356","author":"Hudes","year":"2007","journal-title":"N Engl J Med"},{"key":"10.2353\/ajpath.2009.080451_bib14","doi-asserted-by":"crossref","first-page":"11484","DOI":"10.1016\/S0021-9258(18)98549-2","article-title":"B lymphocyte activation is accompanied by phosphorylation of a 72-kDa protein-tyrosine kinase","volume":"266","author":"Hutchcroft","year":"1991","journal-title":"J Biol Chem"},{"key":"10.2353\/ajpath.2009.080451_bib15","doi-asserted-by":"crossref","first-page":"5429","DOI":"10.4049\/jimmunol.152.11.5429","article-title":"Stimulation of macrophage Fc gamma RIIIA activates the receptor-associated protein tyrosine kinase Syk and induces phosphorylation of multiple proteins including p95Vav and p62\/GAP-associated protein","volume":"152","author":"Darby","year":"1994","journal-title":"J Immunol"},{"key":"10.2353\/ajpath.2009.080451_bib16","doi-asserted-by":"crossref","first-page":"9107","DOI":"10.1073\/pnas.89.19.9107","article-title":"Fc epsilon RI-mediated tyrosine phosphorylation and activation of the 72-kDa protein-tyrosine kinase, PTK72, in RBL-2H3 rat tumor mast cells","volume":"89","author":"Hutchcroft","year":"1992","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.2353\/ajpath.2009.080451_bib17","doi-asserted-by":"crossref","first-page":"8613","DOI":"10.1016\/S0021-9258(18)42487-8","article-title":"Association of the 72-kDa proteintyrosine kinase PTK72 with the B cell antigen receptor","volume":"267","author":"Hutchcroft","year":"1992","journal-title":"J Biol Chem"},{"key":"10.2353\/ajpath.2009.080451_bib18","doi-asserted-by":"crossref","first-page":"15900","DOI":"10.1016\/S0021-9258(18)82337-7","article-title":"Involvement of p72syk, a protein-tyrosine kinase, in Fc gamma receptor signaling","volume":"268","author":"Agarwal","year":"1993","journal-title":"J Biol Chem"},{"key":"10.2353\/ajpath.2009.080451_bib19","doi-asserted-by":"crossref","first-page":"5918","DOI":"10.1016\/S0021-9258(17)37549-X","article-title":"Differential control of the tyrosine kinases Lyn and Syk by the two signaling chains of the high affinity immunoglobulin E receptor","volume":"269","author":"Jouvin","year":"1994","journal-title":"J Biol Chem"},{"key":"10.2353\/ajpath.2009.080451_bib20","doi-asserted-by":"crossref","first-page":"24442","DOI":"10.1016\/S0021-9258(20)80545-6","article-title":"Cross-linking of Fc gamma eceptor I (Fc gamma RI) and receptor II (Fc gamma RII) on monocytic cells activates a signal transduction pathway common to both Fc receptors that involves the stimulation of p72 Syk protein tyrosine kinase","volume":"268","author":"Kiener","year":"1993","journal-title":"J Biol Chem"},{"key":"10.2353\/ajpath.2009.080451_bib21","doi-asserted-by":"crossref","first-page":"4156","DOI":"10.1182\/blood-2006-05-026203","article-title":"Syk-dependent mTOR activation in follicular lymphoma cells","volume":"108","author":"Leseux","year":"2006","journal-title":"Blood"},{"key":"10.2353\/ajpath.2009.080451_bib22","doi-asserted-by":"crossref","first-page":"7800","DOI":"10.1158\/0008-5472.CAN-04-4180","article-title":"Activation of mTOR in transformed B lymphocyte is nutrient-dependent but independent of Akt. MEK, IGF-I, and serum","volume":"65","author":"Wlodarski","year":"2005","journal-title":"Cancer Res"},{"key":"10.2353\/ajpath.2009.080451_bib23","doi-asserted-by":"crossref","first-page":"2181","DOI":"10.1182\/blood-2007-06-095182","article-title":"IL-2- and IL-15-induced activation of the rapamycin-sensitive mTORC1 pathway in malignant CD4+ T lymphocytes","volume":"111","author":"Marzec","year":"2008","journal-title":"Blood"},{"key":"10.2353\/ajpath.2009.080451_bib24","doi-asserted-by":"crossref","first-page":"5606","DOI":"10.1038\/sj.onc.1210346","article-title":"Oncogenic tyrosine kinase NPM\/ALK induces activation of the rapamycin-sensitive mTOR signaling pathway","volume":"26","author":"Marzec","year":"2007","journal-title":"Oncogene"},{"key":"10.2353\/ajpath.2009.080451_bib25","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1038\/labinvest.3700494","article-title":"Constitutive activation of mTOR signaling pathway in post-transplant lymphoproliferative disorders (PTLDs)","volume":"87","author":"El-Salem","year":"2007","journal-title":"Lab Invest"},{"key":"10.2353\/ajpath.2009.080451_bib26","doi-asserted-by":"crossref","first-page":"4285","DOI":"10.1073\/pnas.080068597","article-title":"Immuno-suppressive macrolide SDZ RAD inhibits growth of human EBV-transformed B lymphocytes in vitro and in vivo; a potential novel approach to prevention and treatment of post-transplant lymphoproliferative disorders (PTLDs)","volume":"97","author":"Majewski","year":"2000","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.2353\/ajpath.2009.080451_bib27","doi-asserted-by":"crossref","first-page":"2165","DOI":"10.1182\/blood-2006-06-028092","article-title":"Rapamycin is efficacious against primary effusion lymphoma (PEL) cell lines in vivo by inhibiting autocrine signaling","volume":"109","author":"Sin","year":"2007","journal-title":"Blood"},{"key":"10.2353\/ajpath.2009.080451_bib28","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/S0165-2478(99)00053-X","article-title":"Involvement of a rapamycin-sensitive pathway in CD40-mediated activation of murine B cells in vitro","volume":"68","author":"Sakata","year":"1999","journal-title":"Immunol Lett"},{"key":"10.2353\/ajpath.2009.080451_bib29","doi-asserted-by":"crossref","first-page":"21960","DOI":"10.1074\/jbc.M300805200","article-title":"Regulation of the phosphatidylinositol 3-kinase. Akt\/protein kinase B, FRAP\/mammalian target of rapamycin, and ribosomal S6 kinase 1 signaling pathways by thyroid-stimulating hormone (TSH) and stimulating type TSH receptor antibodies in the thyroid gland","volume":"278","author":"Suh","year":"2003","journal-title":"J Biol Chem"},{"key":"10.2353\/ajpath.2009.080451_bib30","doi-asserted-by":"crossref","first-page":"19937","DOI":"10.1074\/jbc.M411865200","article-title":"The mTOR-S6K1 but not PI3K-Akt signaling is responsible for fibroblast growth factor-9-induced cell proliferation","volume":"280","author":"Wing","year":"2005","journal-title":"J Biol Chem"},{"key":"10.2353\/ajpath.2009.080451_bib31","doi-asserted-by":"crossref","first-page":"5466","DOI":"10.1073\/pnas.0509694103","article-title":"The mTOR pathway is regulated by polycystin-1, and its inhibition reverses renal cystogenesis in polycystic kidney disease","volume":"103","author":"Shillingford","year":"2006","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.2353\/ajpath.2009.080451_bib32","doi-asserted-by":"crossref","first-page":"26904","DOI":"10.1074\/jbc.M605371200","article-title":"AKT-independent phosphorylation of TSC2 and activation of mTOR and ribosomal protein S6 kinase signaling by prostaglandin F2alpha","volume":"281","author":"Arvisais","year":"2006","journal-title":"J Biol Chem"},{"key":"10.2353\/ajpath.2009.080451_bib33","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1182\/blood-2006-08-039883","article-title":"Notch signals positively regulate activity of the mTOR pathway in T cell acute lymphoblastic leukemia","volume":"110","author":"Chan","year":"2007","journal-title":"Blood"},{"key":"10.2353\/ajpath.2009.080451_bib34","doi-asserted-by":"crossref","first-page":"5499","DOI":"10.1128\/JVI.79.9.5499-5506.2005","article-title":"Modulation of the cell growth regulator mTOR by Epstein-Barr virus-encoded LMP2A","volume":"79","author":"Moody","year":"2005","journal-title":"J Virol"},{"key":"10.2353\/ajpath.2009.080451_bib35","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.ccr.2006.05.026","article-title":"The TSC2\/mTOR pathway drives endothelial cell transformation induced by the Kaposi's sarcoma-associated herpesvirus G protein-coupled receptor","volume":"10","author":"Sodhi","year":"2006","journal-title":"Cancer Cell"},{"key":"10.2353\/ajpath.2009.080451_bib36","doi-asserted-by":"crossref","first-page":"1710","DOI":"10.1097\/01.TP.0000063934.89714.19","article-title":"Immunosuppressive signal transduction inhibitor RAD suppresses growth of cells derived from post-transplant lymphoproliferative disorder at allograft protecting doses","volume":"75","author":"Majewski","year":"2003","journal-title":"Transplantation"},{"key":"10.2353\/ajpath.2009.080451_bib37","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1111\/j.1432-2277.2003.tb00287.x","article-title":"Rituximab in association with rapamycin for post-transplant lymphoproliferative disease treatment","volume":"16","author":"Garcia","year":"2003","journal-title":"Transpl Int"},{"key":"10.2353\/ajpath.2009.080451_bib38","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1111\/j.1399-3046.2004.00156.x","article-title":"Sirolimus for pediatric liver transplant recipients with post-transplant lymphoproliferative disease and hepatoblastoma","volume":"8","author":"Jim\u00e9nez-Rivera","year":"2004","journal-title":"Pediatr Transplant"},{"key":"10.2353\/ajpath.2009.080451_bib39","doi-asserted-by":"crossref","first-page":"1748","DOI":"10.1093\/ndt\/gfh884","article-title":"Resolution of renal allograft-associated post-transplant lymphoproliferative disorder with the introduction of sirolimus","volume":"20","author":"Zaltzman","year":"2005","journal-title":"Nephrol Dial Transplant"},{"key":"10.2353\/ajpath.2009.080451_bib40","doi-asserted-by":"crossref","first-page":"e67","DOI":"10.1053\/j.ajkd.2006.01.029","article-title":"Sirolimus-induced remission of post transplantation lymphoproliferative disorder","volume":"47","author":"Cullis","year":"2006","journal-title":"Am J Kidney Dis"},{"key":"10.2353\/ajpath.2009.080451_bib41","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1016\/j.transproceed.2007.03.092","article-title":"Complete regression of cutaneous B-cell lymphoma in a renal transplant patient after conversion from cyclosporin to sirolimus","volume":"39","author":"Mohsin","year":"2007","journal-title":"Transplant Proc"},{"key":"10.2353\/ajpath.2009.080451_bib42","first-page":"2036","article-title":"Conversion to rapamycin immunosuppression for malignancy after kidney transplantation: case reports","volume":"39","author":"Iaria","year":"2007","journal-title":"TransplantProc"},{"key":"10.2353\/ajpath.2009.080451_bib43","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1111\/j.1432-2277.2008.00655.x","article-title":"Inhibition of mTOR by sirolimus induces remission of post-transplant lymphoproliferative disorders","volume":"21","author":"Boratynska","year":"2008","journal-title":"Transpl Int"},{"key":"10.2353\/ajpath.2009.080451_bib44","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1097\/01.TP.0000115344.18025.0B","article-title":"Conversion to sirolimus: a successful treatment for post transplantation Kaposi's sarcoma","volume":"77","author":"Campistol","year":"2004","journal-title":"Transplantation"},{"key":"10.2353\/ajpath.2009.080451_bib45","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1056\/NEJMoa042831","article-title":"Sirolimus for Kaposi's sarcoma in renal- transplant recipients","volume":"352","author":"Stallone","year":"2005","journal-title":"N Engl J Med"},{"key":"10.2353\/ajpath.2009.080451_bib46","doi-asserted-by":"crossref","first-page":"4070","DOI":"10.1093\/emboj\/cdf391","article-title":"Sequential involvement of Cdk1, mTOR and p53 in apoptosis induced by the HIV-1 envelope","volume":"21","author":"Castedo","year":"2002","journal-title":"EMBO J"},{"key":"10.2353\/ajpath.2009.080451_bib47","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1016\/j.biochi.2003.08.006","article-title":"Cell death and inflam-mation during infection with the obligate intracellular pathogen","volume":"85","author":"Perfettini","year":"2003","journal-title":"Chlamydia Biochim"},{"key":"10.2353\/ajpath.2009.080451_bib48","doi-asserted-by":"crossref","first-page":"3832","DOI":"10.1182\/blood-2005-09-3600","article-title":"AIDS-related non-Hodgkin lymphoma: final analysis of 485 patients treated with risk-adapted intensive chemotherapy","volume":"107","author":"Mounier","year":"2006","journal-title":"Blood"},{"key":"10.2353\/ajpath.2009.080451_bib49","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1097\/01.qco.0000200295.30285.13","article-title":"AIDS-related malignancies: changing epidemiology and the impact of highly active antiretroviral therapy","volume":"19","author":"Bower","year":"2006","journal-title":"Curr Opin Infect Dis"}],"container-title":["The American Journal of Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002944010605937?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002944010605937?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,5,26]],"date-time":"2023-05-26T01:24:10Z","timestamp":1685064250000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002944010605937"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,8]]},"references-count":49,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2009,8]]}},"alternative-id":["S0002944010605937"],"URL":"https:\/\/doi.org\/10.2353\/ajpath.2009.080451","relation":{},"ISSN":["0002-9440"],"issn-type":[{"value":"0002-9440","type":"print"}],"subject":[],"published":{"date-parts":[[2009,8]]}}}